Ductal Carcinoma In Situ Close to the Inked Margin: A Case Presented in Multidisciplinary Session With Clinical Discussion and Decision Making

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 265

This Paper With 5 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ARCHB-5-2_003

تاریخ نمایه سازی: 24 خرداد 1400

Abstract:

Background: For many years, the acceptable margins of the resections forductal carcinoma in situ (DCIS) has been ۲ mm, although, in some reports and therecent updates of some guidelines, the closer margins are also declared asacceptable in some circumstances. Despite these new recommendations, the safemargin in DCIS remains a matter of controversy in many institutional and nationalguidelines. Case Presentation: A woman with invasive breast cancer with associated DCISpresented to our clinic. She underwent breast-conserving surgery, and pathologyreport showed one focus of DCIS at a distance of < ۱ mm from inked margin. Thiscase was presented in the weekly breast multidisciplinary team session of theDepartment of Breast Surgery, Tehran University of Medical Sciences. Question: The question was whether the patient should be operated again toobtain more extensive margins for DCIS or the radiation therapy would be enoughas the next step in her treatment. Conclusion: According to the latest published guidelines, the members of paneldecided to accept the margin and informed the patient about the risk of recurrenceand the need for adjuvant radiotherapy and follow-up modalities.

Keywords:

Breast cancer , ductal carcinoma In situ (DCIS(و inked margin , multidisciplinary team decision

Authors

Ahmad Elahi

Division of Breast Surgical Oncology, Department of Surgery, Alborz University of Medical Sciences, Karaj, Iran

Gholamreza Toogeh

Hematology and Medical Oncology Department, Thrombosis Hemostasis Research Center, Tehran University ofMedical Sciences, Tehran, Iran

Habibollah Mahmoodzadeh

Division of Surgical Oncology, Department of Surgery, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

Behnaz Jahanbin

Cancer Research Center, Department of Pathology, Tehran University of Medical Sciences, Tehran, Iran

Farhad Shahi

Hematology and Medical Oncology Department, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

Bita Kalaghchi

Radiation Oncology Research center, Department of Radiation Oncology, Tehran University of Medical Sciences, Tehran, Iran